AGENDA
Anti-Infective Drugs Advisory Committee
Food and Drug Administration
Ramada Inn, Bethesda, MD
Wednesday, March 5, 1997
OPEN SESSION
PART II
GUIDANCE TO INDUSTRY - EVALUATING CLINICAL STUDIES OF ANTIMICROBIALS IN THE DIVISION OF ANTI-INFECTIVE DRUG PRODUCTS EVALUABILITY CRITERIA FOR INDIVIDUAL INDICATIONS
5:30-6:00 Open Public Hearing
Holiday Inn, Bethesda, MD
Thursday, March 6, 1997
OPEN SESSION
8:30-10:10 PNEUMONIA
(Community-Acquired and Nosocomial)
10:30-12:00 BRONCHITIS
(Acute Exacerbations of Chronic Bronchitis and
Secondary Bacterial Infections of Acute Bronchitis)
1:00-2:00 UNCOMPLICATED GONORRHEA
2:00-3:15 ACUTE SINUSITIS
3:30-5:00 ACUTE OTITIS MEDIA
FDA Presentation Brad Leissa, M.D.
Committee Presentation Marian Melish, M.D.
Richard Swartz, M.D.
Discussion
Friday, March 7, 1997
OPEN SESSION
8:30-10:00 UNCOMPLICATED URINARY TRACT INFECTIONS
10:20-12:00 SKIN AND SKIN STRUCTURE
(Uncomplicated and Complicated)
Date created: June 3, 1997; last update: July 8, 2005 |